Dublin, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/2lg99t/biologics_and)
has announced the addition of the "Biologics
and Biosimilars World Markets" report to their offering.
Biologics, also known as biopharmaceuticals, can be categorized into three main modalities: therapeutic proteins, monoclonal antibodies and vaccines. Most of the biologic drugs marketed so far are recombinant therapeutic protein drugs, which are used to relieve patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular diseases, infertility and cystic fibrosis. Globally, the U.S. commands 43% of biologics sales, followed by the E.U. (21%) and Japan (9%).
The "Expanding Markets for Biologics and Biosimilars" report covers key biologic and biosimilar drugs, including:
- Humira (Adalimumab)
- Remicade (Infliximab)
- Lantus (Insulin Glargine)
- Levemir (Insulin Detemir)
- Privigen (Immune Globulin Intravenous)
- Perjeta (Pertuzumab)
- Soliris (Eculizumab)
- Eylea (Aflibercept)
- Revlimid (Lenalidomide)
- Herceptin (Trastuzumab)
- Gardasil
- Varivax (Varicella Virus Vaccine Live)
- Gammagard Liquid (Immune Globulin Infusion (Human))
- Aranesp (Darbepoetin Alfa)
- Enbrel (Etanercept)
- Epogen/Procrit/Eprex/Erypo (Epoetin Alfa)
- Genotropin (Somatropin)
- Herceptin (Trastuzumab)
- Humira (Adalimumab)
- Neulasta (Pegfilgrastim)
- Neupogen (Filgrastim)
- Remicade (Infliximab)
- Rituxan/MabThera (Rituximab)
The "Expanding Markets for Biologics and Biosimilars" report examines companies manufacturing biologic and biosimilar equipment and supplies in the world.
Companies covered include:
- AbbVie, Inc
- Abbott Laboratories
- Actelion Ltd
- Amgen, Inc
- Amoytop Biotech Co, Ltd
- Anhui Anke Biotechnology (Group) Co, Ltd
- Apotex, Inc
- Astellas Pharma, Inc
- AstraZeneca
- Bayer AG
- Beijing Four Rings Biopharmaceuticals
- Bharat Serums and Vaccines Limited
- Bio, Inc
- Biocon Ltd
- Biogen Idec, Inc
- Bioton SA
- Boehringer Ingelheim Pharmaceuticals, Inc
- Bristol-Myers Squibb, Co
- Celgene Corporation
- Celltrion, Inc
- Cipla Ltd
- Dr Reddy's Laboratories Ltd
- Elan Corporation, PLC
- Eli Lilly & Co
- Gideon Richter
- Gilead Sciences, Inc
- GlaxoSmithKline PLC
- Hospira, Inc
- Intas Pharmaceuticals Limited
- Johnson & Johnson
- Merck & Co, Inc
- Mylan, Inc
- Novartis AG
- Pfizer, Inc
- Roche Holdings AG
- Sandoz International GmbH
- Sanofi
- Stada Arzneimittel Aktiengesellschaft
- Teva Pharmaceutical Industries Limited
- Watson Pharmaceuticals, Inc
Detailed charts with sales forecasts and marketshare data are
included.
For more information visit http://www.researchandmarkets.com/research/2lg99t/biologics_and
About Research and Markets
Research and Markets is the world's leading source for
international market research reports and market data. We provide
you with the latest data on international and regional markets, key
industries, the top companies, new products and the latest
trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Pharmaceuticals